Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 1091-1098

  Aupperle, Karlfried R ^a   Boyle, David L ^a   Hendrix, Mary ^b   Seftor, Elisabeth A ^b   Zvaifler, Nathan J ^a   Barbosa, Miguel ^c   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA FRAGMENT; HYDROGEN PEROXIDE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; NEOMYCIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; RHEUMATOID ARTHRITIS; SOMATIC MUTATION; SYNOVIOCYTE; TUMOR SUPPRESSOR GENE;

APOPTOSIS; ARTHRITIS, RHEUMATOID; BLOTTING, NORTHERN; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; COLLAGENASES; FLOW CYTOMETRY; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-1; NITROPRUSSIDE; ONCOGENE PROTEINS, VIRAL; PLATELET-DERIVED GROWTH FACTOR; REPRESSOR PROTEINS; SYNOVIAL MEMBRANE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031922066     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Lane DP: Cancer: p53, guardian of the genome. Nature 1992, 358: 15-16
2. Harris AL: Mutant p53-the commonest genetic abnormality in human cancer? J Pathol 1990, 162:5-6
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53
4. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995, 96:1631-1638
5. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995, 38:485-491
6. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996, 149:2143-2151
7. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996, 55:442-449
8. Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S: Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996, 23:1345-1352
9. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green D: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1998 (in press)
10. Beroud C, Verdier F, Soussi T: p53 gene mutation: software and database. Nucleic Acids Res 1996, 24:147-150
11. Barbosa MS: The oncogenic role of human papillomavirus proteins. Grit Rev Oncog 1996, 7:1-18
12. Mietz JA, Linger T, Huibregtse JM, Howley PM: The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 1992, 11:5013-5020
13. Pim D, Storey A, Thomas M, Massimi P, Banks L: Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 1994, 9:1869-1876
14. Huibregtse JM, Scheffner M, Howley PM: A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 1991, 10:4129-4135
15. Band V, De Caprio JA, Delmolino L, Kulesa V, Sager R: Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol 1991, 65:6671-6676
16. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
18. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Cytokines in chronic inflammatory arthritis: V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage-colony stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990, 86:1790-1798
19. Miller AD, Bender MA, Harris EA, Kaleko M, Gelinas RE: Design of retrovirus vectors for transfer and expression of the human β-globin gene. J Virol 1988, 62:4337-4345
20. Hu TH, Ferril SC, Snider AM, Barbosa MS: In vivo analysis of HPV E7 protein association with pRb, p107, and p130. Int J Oncol 1995, 6:167-174
21. Peters DM, Dowd N, Brandt C, Compton T: Human papilloma virus E6/E7 genes can expand the lifespan of human corneal fibroblasts. In Vitro Cell Dev Biol Anim 1996, 32:279-284
22. Xiong Y, Kuppuswamy D, Li Y, Livano EM, Hixon M, White A, Beach D, Tlsty TD: Alteration of cell cycle kinase complexes in human papillomavirus E6-and E7-expressing fibroblasts precedes neoplastic transformation. J Virol 1996, 70:999-1008
23. Band V, De Caprio JA, Delmolino L, Kulesa V, Sager R: Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol 1991, 65:6671-6676
24. Kaur P, McDougall JK: HPV-18 immortalization of human keratinocytes. Virology 1989, 173:302-310
25. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT: HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989, 8:3905-3910
26. Frye CA, Yocum DE, Tuan R, Suyana E, Seftor EA, Seftor REB, Khalkhali-Ellis Z, Moore TL, Hendrix MJC: An in vitro model for studying mechanisms underlying synoviocyte-mediated cartilage invasion in rheumatoid arthritis. Pathol Oncol Res 1996, 2:157-166
27. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Alpha 4/β 1 integrin(VLA-4)ligands in arthritis: vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992, 149:1424-1431
28. Firestein GS: Etiology and pathogenesis of rheumatoid arthritis. Textbook of Rheumatology, ed 5. Edited by WN Kelley, et al. Philadelphia, W.B. Saunders Co., 1996, pp 851-897
29. Firestein GS: Invasive fibroblas-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? Arthritis Rheum 1996, 39:1781-1790
30. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL: Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J Clin Invest 1989, 83:1267-1276
31. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996, 149:1607-1615
32. Ueda N, Shah SV: Endonuclease-induced DNA damage, and cell death inoxidant injury to renal tubular epithelial cells. J Clin Invest 1992, 90:2593-2597
33. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS, et al: DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991, 254:1001-1003
34. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992, 89:3030-3034
35. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 1992, 11:3045-3052
36. Hubbert NL, Sedman SA, Schiller JT: Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J Virol 1992, 66:6237-6241
37. Steller MA, Zou Z, Schiller JT, Baserga R: Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor. Cancer Res 1996, 56:5087-5091
38. Thomas M, Matlashewski G, Pim D, Banks L: Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene 1996, 13:265-273
39. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR, Schiller JT: The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol 1991, 65:4860-4866
40. Barbosa MS, Vass WC, Lowy DR, Schiller JT: In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol 1991, 65:292-298
41. Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989, 57:1083-1093
42. Zambetti GP, Olson D, Labow M, Levine AJ: A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Proc Natl Acad Sci USA 1992, 89:3952-3956
43. Remmers EF, Sano H, Lafyatis R, Case JP, Kumkumian GK, Hla T, Maciag T, Wilder RL: Production of platelet derived growth factor B chain(PDGF-B/c-sis)mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: coexpression with heparin binding acidic fibroblast growth factor-1. J Rheumatol 1991, 18:7-13
44. Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS: Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value. Proc Natl Acad Sci USA 1996, 93:1093-1096
45. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI: Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 1997, 132:371-374
46. Campbell C, Quinn AG, Ro YS, Angus B, Rees JL: p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 1993, 100:746-748
47. Messmer UK, Brune B: Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem J 1996, 319:299-305
48. Ho YS, Wang YJ, Lin JK: Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinogen 1996, 16:20-31
49. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY: Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996, 184:1519-1524
50. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995, 96:2357-2363